Fermenta Biotech Reports On Sustainability, Detailing ESG Metrics and Operational Health for FY 2025-26

Fermenta Biotech Reports On Sustainability, Detailing ESG Metrics and Operational Health for FY 2025-26​

Fermenta Biotech Limited has released its Business Responsibility and Sustainability Report (BRSR) detailing corporate practices and environmental impact for the financial year 2025-26. The report provides extensive insights into the company’s manufacturing operations, resource management, workforce welfare, and commitment to ethical governance.

The company, which was incorporated in 1951, operates with a focus on sustainable and responsible business conduct, aligning with national guidelines for responsible business practices. Fermenta Biotech Ltd., listed on BSE Limited, reports its financial data on a standalone basis. The company’s paid-up capital stands at ` 14,71,54,935/-.

Business Operations and Market Reach​

Fermenta's core business is the manufacturing of Active Pharmaceutical Ingredients, Aqua CHL, Biotechnology, and Nutraceutical products, which accounts for 96.4% of the entity’s turnover. The company offers a range of products, including Vitamin D3 Product range, Phenyramidol HCl and Silicon Dry Powder (87.0%), alongside other pharmaceutical and botanical products (6.0%) and Environmental Solutions (3.4%).

The company serves markets both nationally—spanning around 20 states—and internationally across approximately 60 countries. Exports constitute a significant portion of the business, accounting for 58% of the total turnover in FY 2025-26. Customers include manufacturers in various sectors such as pharmaceuticals and dietary supplements, green chemistry companies, and real estate industry entities requiring environmental solutions.

Workforce and Corporate Social Responsibility (CSR)​

As of March 31, 2026, Fermenta Biotech reported a total workforce size encompassing both employees and workers. There are 563 employees (including 41 female members) and 328 workers (including 6 female members).

The company maintains strong commitment to employee welfare and training.

• Of the 535 permanent employees, 92.34% are male and 7.66% are female.
• For all categories of staff, training in health and safety measures achieved a 100% coverage rate across both employees and workers for the financial year FY 2025-26.

Regarding governance and oversight, the Board of Directors is identified as the highest authority responsible for implementing the Business Responsibility policy. Mr. Prashant Nagre, Managing Director, serves as the designated committee member for sustainability related issues.

Resource Management and Environmental Impact Metrics​

The BRSR provided detailed metrics on resource consumption, waste management, and environmental emissions across various operational areas.

Water and Energy Consumption (FY 2025-26):
The company reported total water consumption of 1,20,919.83 kiloliters for the fiscal year. This resulted in a water intensity of 0.027656355 per rupee of turnover. Regarding energy consumption, the company recorded total electricity consumption of 1,70,33,875.2 MJ, resulting in an energy intensity of 0.035824525.

Air and Waste Management:
For FY 2025-26, air emissions data showed NOx at 518.25 mg/nm3 and SOx at 107.73 mg/nm3. The company managed its waste generation responsibly, with total waste generated reported at 1,911.80 metric tonnes. A significant effort was directed towards recovery, with 1,182.653 metric tonnes being recovered through recycling and other recovery operations.

Operational Efficiency:
The business demonstrated efficiency in procurement, recording a concentration of purchases from trading houses at 44% for FY 2025-26 (up from 24% in FY 2024-25). Furthermore, sales to dealers or distributors accounted for 14.04% of total sales in the same period.

Corporate Compliance and Grievance Redressal​

Fermenta Biotech Ltd. maintains robust systems for compliance and grievance redressal across various stakeholders. The company states that its policies cover all nine principles (P1-P9) of the National Guidelines on Responsible Business Conduct, and these practices are reviewed periodically by the Board of Directors.

A focus was placed on stakeholder relations:

• Customer Complaints: In FY 2025-26, the company received 12 complaints from customers related to various principles, with zero pending resolution.
• Shareholder Complaints: The company also recorded 3 complaints regarding shareholders in the same period, all of which were resolved.

The company's manufacturing site at Kullu, Himachal Pradesh, operates as a Zero Liquid Discharge Site, recycling treated water for utility purposes according to CTO conditions.

FERMENTA Stock Price Movement​

Today, shares of Fermenta Biotech Limited edged higher to settle at ₹443.90 after climbing 2.36%. The stock saw heavy trading during the day, with a volume of 151,112 shares recorded in the session.